Five-Year Results of a Phase 3 Trial of Hypofractionated vs. Conventional Postprostatectomy Radiotherapy: NRG Oncology GU003
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S38-S39
DOI: 10.1016/j.ijrobp.2026.06.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von M.K. Buyyounouski und 19 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Buyyounouski, M., Borges, M., Chen, R., Mann, M., Kudchadker, R., Konski, A., Tendulkar, R., Michalski, J., Vigneault, E., Kilburn, J., Valicenti, R., Potters, L., Currey, A., Barkati, M., Schroeder, T., Kittel, J., Desai, N., Pugh, S., Nguyen, P., & Sandler, H. (2026). Five-Year Results of a Phase 3 Trial of Hypofractionated vs. Conventional Postprostatectomy Radiotherapy: NRG Oncology GU003. International Journal of Radiation Oncology*Biology*Physics, 126(1), S38-S39. https://doi.org/10.1016/j.ijrobp.2026.06.009
Vancouver
Buyyounouski M, Borges M, Chen R, Mann M, Kudchadker R, Konski A, et al. Five-Year Results of a Phase 3 Trial of Hypofractionated vs. Conventional Postprostatectomy Radiotherapy: NRG Oncology GU003. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S38-S39. doi:10.1016/j.ijrobp.2026.06.009
BibTeX
@article{Buyyounouski2026,
author = {Buyyounouski, M.K. and Borges, M. and Chen, R.C. and Mann, M. and Kudchadker, R. and Konski, A.A. and Tendulkar, R.D. and Michalski, J.M. and Vigneault, E. and Kilburn, J.M. and Valicenti, R.K. and Potters, L. and Currey, A.D. and Barkati, M. and Schroeder, T.M. and Kittel, J. and Desai, N.B. and Pugh, S. and Nguyen, P.L. and Sandler, H.M.},
title = {Five-Year Results of a Phase 3 Trial of Hypofractionated vs. Conventional Postprostatectomy Radiotherapy: NRG Oncology GU003},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {S38--S39},
doi = {10.1016/j.ijrobp.2026.06.009}
}
EUVIMED